168 related articles for article (PubMed ID: 7025156)
21. Clinical studies of pneumococcal vaccines in infants. II. Efficacy and effect on nasopharyngeal carriage.
Wright PF; Sell SH; Vaughn WK; Andrews C; McConnell KB; Schiffman G
Rev Infect Dis; 1981; 3 Suppl():S108-12. PubMed ID: 7280442
[TBL] [Abstract][Full Text] [Related]
22. Streptococcus pneumoniae polysaccharide vaccine: age and dose responses, safety, persistence of antibody, revaccination, and simultaneous administration of pneumococcal and influenza vaccines.
Hilleman MR; Carlson AJ; McLean AA; Vella PP; Weibel RE; Woodhour AF
Rev Infect Dis; 1981; 3 Suppl():S31-42. PubMed ID: 7025159
[TBL] [Abstract][Full Text] [Related]
23. Prevention of pneumococcal infection by immunization with capsular polysaccharides of Streptococcus pneumoniae: current status of polyvalent vaccines.
Austrian R
J Infect Dis; 1977 Aug; 136 Suppl():S38-42. PubMed ID: 19543
[TBL] [Abstract][Full Text] [Related]
24. Antibody responses of splenectomized patients with non-Hodgkin's lymphoma to immunization with polyvalent pneumococcal vaccines.
Petrasch S; Kühnemund O; Reinacher A; Uppenkamp M; Reinert R; Schmiegel W; Lütticken R; Brittinger G
Clin Diagn Lab Immunol; 1997 Nov; 4(6):635-8. PubMed ID: 9384280
[TBL] [Abstract][Full Text] [Related]
25. Immunization of renal transplant recipients with pneumococcal polysaccharide vaccine.
Kazancioğlu R; Sever MS; Yüksel-Onel D; Eraksoy H; Yildiz A; Celik AV; Kayacan SM; Badur S
Clin Transplant; 2000 Feb; 14(1):61-5. PubMed ID: 10693637
[TBL] [Abstract][Full Text] [Related]
26. Timing of vaccination does not affect antibody response or survival after pneumococcal challenge in splenectomized rats.
Schreiber MA; Pusateri AE; Veit BC; Smiley RA; Morrison CA; Harris RA
J Trauma; 1998 Oct; 45(4):692-7; discussion 697-9. PubMed ID: 9783606
[TBL] [Abstract][Full Text] [Related]
27. Pneumococcal vaccine: clinical efficacy and effectiveness.
Schwartz JS
Ann Intern Med; 1982 Feb; 96(2):208-20. PubMed ID: 6800290
[TBL] [Abstract][Full Text] [Related]
28. Rapid decline of anti-pneumococcal antibody levels in nephrotic children.
Güven AG; Akman S; Bahat E; Senyurt M; Yüzbey S; Uguz A; Yegin O
Pediatr Nephrol; 2004 Jan; 19(1):61-5. PubMed ID: 14648335
[TBL] [Abstract][Full Text] [Related]
29. A study of the pneumococcal vaccine in prevention of clinically acute atttacks of recurrent otitis media.
Mäkelä PH; Leinonen M; Pukander J; Karma P
Rev Infect Dis; 1981; 3 Suppl():S124-32. PubMed ID: 6974386
[TBL] [Abstract][Full Text] [Related]
30. Serum antibody and opsonic responses to vaccination with pneumococcal capsular polysaccharide in normal and splenectomized children.
Giebink GS; Foker JE; Kim Y; Schiffman G
J Infect Dis; 1980 Mar; 141(3):404-12. PubMed ID: 6988526
[No Abstract] [Full Text] [Related]
31. Response to pneumococcal vaccination in children with nephrotic syndrome.
Wilkes JC; Nelson JD; Worthen HG; Morris M; Hogg RJ
Am J Kidney Dis; 1982 Jul; 2(1):43-6. PubMed ID: 7102663
[TBL] [Abstract][Full Text] [Related]
32. Preserved antibody levels and loss of memory B cells against pneumococcus and tetanus after splenectomy: tailoring better vaccination strategies.
Rosado MM; Gesualdo F; Marcellini V; Di Sabatino A; Corazza GR; Smacchia MP; Nobili B; Baronci C; Russo L; Rossi F; Vito RD; Nicolosi L; Inserra A; Locatelli F; Tozzi AE; Carsetti R
Eur J Immunol; 2013 Oct; 43(10):2659-70. PubMed ID: 23813052
[TBL] [Abstract][Full Text] [Related]
33. [Pneumococcal vaccination of splenectomized patients. Recommendations based on a 10-year experience].
Konradsen HB; Henrichsen J
Ugeskr Laeger; 1991 Oct; 153(43):2999-301. PubMed ID: 1801383
[TBL] [Abstract][Full Text] [Related]
34. Immunogenicity and safety of a 23-valent pneumococcal polysaccharide vaccine in healthy children and in children at increased risk of pneumococcal infection.
Lee HJ; Kang JH; Henrichsen J; Konradsen HB; Jang SH; Shin HY; Ahn HS; Choi Y; Hessel L; Nam SW
Vaccine; 1995 Nov; 13(16):1533-8. PubMed ID: 8578838
[TBL] [Abstract][Full Text] [Related]
35. Pneumococcal capsular polysaccharide vaccination in adult chronic hemodialysis patients.
Katz LA; Simberkoff MS; Schiffman G; Spicehandler JR; Moldover NH; Rahal JJ
Trans Am Soc Artif Intern Organs; 1980; 26():369-71. PubMed ID: 7245515
[No Abstract] [Full Text] [Related]
36. Antibody responses in postsplenectomy trauma patients receiving the 23-valent pneumococcal polysaccharide vaccine at 14 versus 28 days postoperatively.
Shatz DV; Romero-Steiner S; Elie CM; Holder PF; Carlone GM
J Trauma; 2002 Dec; 53(6):1037-42. PubMed ID: 12478024
[TBL] [Abstract][Full Text] [Related]
37. A longitudinal study of class and subclass antibody response to pneumococcal vaccination in splenectomized individuals with special reference to patients with Hodgkin's disease.
Grimfors G; Söderqvist M; Holm G; Lefvert AK; Björkholm M
Eur J Haematol; 1990 Aug; 45(2):101-8. PubMed ID: 2209812
[TBL] [Abstract][Full Text] [Related]
38. Pneumococcal vaccine failure in a splenectomized child.
Koren A; Efrati Z; Algazi J; Katzuni E
Infect Control; 1984 Dec; 5(12):556. PubMed ID: 6569852
[No Abstract] [Full Text] [Related]
39. Antibody response and opsonization afer pneumococcal vaccination in splenectomized children and healthy persons.
Johansen KS; Pedersen FK
Acta Pathol Microbiol Immunol Scand C; 1982 Oct; 90(5):265-70. PubMed ID: 7180463
[TBL] [Abstract][Full Text] [Related]
40. Immunogenicity of 13-Valent Conjugate Pneumococcal Vaccine in Patients 50 Years and Older with End-Stage Renal Disease and on Dialysis.
Mitra S; Stein GE; Bhupalam S; Havlichek DH
Clin Vaccine Immunol; 2016 Nov; 23(11):884-887. PubMed ID: 27581438
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
